Red Cell Partners
Grant Verstandig has a diverse work experience, including being the Co-Founder & Executive Chairman of DEFCON AI since June 2022. Grant is also the Director on the Board of Directors for The OSS Society since May 2022. In addition, they serve as a Member of the Board of Directors for Envisagenics since October 2021 and Zephyr AI since April 2021. Grant is a Member of the Board of Directors for the Greater Washington Partnership since January 2017 and the International Spy Museum since July 2021. Grant is also a Board Member of the THIRD OPTION FOUNDATION since July 2021 and NexImmune, Inc. since November 2020. Prior to that, Grant was the Co-Founder, Chairman & CEO of Red Cell Partners starting in October 2020 and a Co-Founder of Epirus since July 2018. Overall, Grant Verstandig has held various leadership positions across different organizations.
Grant Verstandig attended Landon School from 1998 to 2008, where they earned their High School Diploma. Grant later attended Brown University from 2008 to 2009, but did not complete a specific degree or field of study.
Red Cell Partners
Red Cell Partners is an incubation firm building rapidly-scalable technology-led companies that are bringing revolutionary advancements to market in three distinct practice areas: healthcare, cyber, and national security. United by a shared sense of duty and deep belief in the power of innovation, Red Cell is developing powerful tools and solutions to address our Nation’s most pressing problems.